STEMI

Interventions for ST-segment elevation acute myocardial infarction

Updated on January 25, 2023
, , , Artur Dziewierz, Tomasz Rakowski

Summary

Early reperfusion therapy is a life-saving treatment for patients with ST-segment elevation myocardial infarction. Primary PCI is the preferred method of reperfusion. However, the advantages of the invasive approach over fibrinolytic therapy may be reduced by late initiation of mechanical reperfusion due to logistical problems related to transportation delay to a hospital with a 24/7 invasive service. To overcome this limitation, regional programmes of the treatment of acute coronary syndromes are being introduced based on the cooperation of a PCI-capable hospital (hub) with ambulances and non-PCI-capable hospitals (spokes). With appropriate planning, only in a small minority of patients the anticipated delay to primary PCI will be so long to require pre- or in-hospital fibrinolytic therapy as a bridge to invasive therapy. PCI technique, as well as adjunctive pharmacotherapy in ST-segment elevation myocardial infarction treatment, differ from standard PCI for stable angina due to the need for rapid intervention on thrombus-containing lesions, which increases the risk of complications including distal embolisation or no-reflow. Modern aggressive antiplatelet therapy and new stent designs have improved the immediate and long-term results of primary PCI.

Networking of acute myocardial infarction treatment

The annual incidence of hospital admission for ST-segment elevation myocardial infarction (STEMI) varies...

Sign in to read
the full chapter

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

References

+
follow us
Copyright © 2024 Europa Group – All rights reserved.
The content of this site is intended for health care professionals.